306 related articles for article (PubMed ID: 24862146)
21. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
[TBL] [Abstract][Full Text] [Related]
22. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
de Jong PG; Coppens M; Middeldorp S
Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
24. [Assessment of bleeding risk in patients with venous thromboembolism: we are still a long way from home].
Klok FA; Huisman MV
Ned Tijdschr Geneeskd; 2016; 160():D140. PubMed ID: 27378261
[TBL] [Abstract][Full Text] [Related]
25. Management of bleeding complications in patients with cancer on DOACs.
Schulman S; Shrum J; Majeed A
Thromb Res; 2016 Apr; 140 Suppl 1():S142-7. PubMed ID: 27067968
[TBL] [Abstract][Full Text] [Related]
26. Development in anticoagulant therapy.
van Doormaal FF; Büller HR; Middeldorp S
Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
[TBL] [Abstract][Full Text] [Related]
27. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
28. New and old anticoagulants in cancer.
Verso M; Agnelli G
Thromb Res; 2012 Apr; 129 Suppl 1():S101-5. PubMed ID: 22682118
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation for venous thromboembolism: what if they bleed?
Palareti G
Hamostaseologie; 2012; 32(1):40-4. PubMed ID: 22009202
[TBL] [Abstract][Full Text] [Related]
30. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
31. How to prevent, treat, and overcome current clinical challenges of VTE.
Van Es J; Eerenberg ES; Kamphuisen PW; Büller HR
J Thromb Haemost; 2011 Jul; 9 Suppl 1():265-74. PubMed ID: 21781263
[TBL] [Abstract][Full Text] [Related]
32. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Brown JD; Goodin AJ; Lip GYH; Adams VR
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboembolism in lymphoma: how effectively are we treating patients?
Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
[TBL] [Abstract][Full Text] [Related]
34. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
35. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
Becattini C; Vedovati MC; Agnelli G
Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
[TBL] [Abstract][Full Text] [Related]
36. New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
den Exter PL; Kooiman J; van der Hulle T; Huisman MV
Best Pract Res Clin Haematol; 2013 Jun; 26(2):163-9. PubMed ID: 23953904
[TBL] [Abstract][Full Text] [Related]
37. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
[TBL] [Abstract][Full Text] [Related]
38. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
Rafii H; Frère C; Benzidia I; Crichi B; Andre T; Assenat E; Bournet B; Carpentier A; Connault J; Doucet L; Durant C; Emmerich J; Gris JC; Hij A; Le Hello C; Madelaine I; Messas E; Ndour A; Villiers S; Marjanovic Z; Ait Abdallah N; Yannoutsos A; Farge D
J Med Vasc; 2020 Feb; 45(1):28-40. PubMed ID: 32057323
[TBL] [Abstract][Full Text] [Related]
39. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
Korin J
Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
[TBL] [Abstract][Full Text] [Related]
40. Management of anticoagulants in the periprocedural period for patients with cancer.
Pudusseri A; Spyropoulos AC
J Natl Compr Canc Netw; 2014 Dec; 12(12):1713-20. PubMed ID: 25505212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
